Drug Shortage Report for AVAMYS
Report ID | 200368 |
Drug Identification Number | 02298589 |
Brand name | AVAMYS |
Common or Proper name | fluticasone furoate nasal spray |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | FLUTICASONE FUROATE |
Strength(s) | 27.5MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL NASAL |
Packaging size | 1x120 |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-07-28 |
Estimated end date | 2023-08-31 |
Actual end date | 2023-08-14 |
Shortage status | Resolved |
Updated date | 2023-08-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-07-28 | English | Compare |
v2 | 2023-07-28 | French | Compare |
v3 | 2023-07-29 | English | Compare |
v4 | 2023-08-15 | English | Compare |
v5 | 2023-08-15 | French | Compare |
Showing 1 to 5 of 5